Belpointe Asset Management’s Eagle Point Credit Company ECC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,349
Closed -$93.3K 1327
2023
Q1
$93.3K Buy
8,349
+97
+1% +$1.05K 0.01% 1352
2022
Q4
$83.5K Buy
+8,252
New +$89.6K 0.01% 1339
2022
Q1
Sell
-7,350
Closed -$103K 1241
2021
Q4
$103K Buy
+7,350
New +$106K 0.01% 1176
2021
Q1
Sell
-13,094
Closed -$132K 1018
2020
Q4
$132K Sell
13,094
-86,115
-87% -$783K 0.01% 846
2020
Q3
$855K Sell
99,209
-1,807
-2% -$14.1K 0.1% 233
2020
Q2
$718K Sell
101,016
-142,513
-59% -$930K 0.09% 224
2020
Q1
$1.67M Sell
243,529
-23,013
-9% -$301K 0.29% 77
2019
Q4
$3.9M Buy
266,542
+34,969
+15% +$532K 0.49% 39
2019
Q3
$3.65M Buy
+231,573
New +$3.94M 0.59% 30
2018
Q4
Sell
-7,798
Closed -$140K 533
2018
Q3
$140K Buy
+7,798
New +$142K 0.02% 549
2018
Q1
Sell
-15,797
Closed -$297K 383
2017
Q4
$297K Sell
15,797
-6,262
-28% -$122K 0.07% 344
2017
Q3
$456K Buy
+22,059
New +$456K 0.11% 214

Other funds holding ECC

Belpointe Asset Management's ECC Position: Q2 2023 in Review

Belpointe Asset Management sold out of Eagle Point Credit Company (ECC) in Q2 2023, closing a stake of 8,349 shares — an estimated $93.3K sold.

Belpointe Asset Management first reported a position in ECC in Q3 2017 and held it in 12 quarters. The position peaked at $3.9M in Q4 2019. 65 funds tracked by Wall St. Rank hold ECC as of Q2 2023.

  • Belpointe Asset Management reported no remaining Eagle Point Credit Company position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 8,349 Eagle Point Credit Company shares in Q2 2023, an estimated $93.3K.
  • Belpointe Asset Management first reported a position in Eagle Point Credit Company in Q3 2017 and held it in 12 quarters.
  • Belpointe Asset Management's Eagle Point Credit Company position peaked at $3.9M in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Eagle Point Credit Company as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.